- Report
- August 2025
- 124 Pages
Global
From €3562EUR$3,999USD£3,109GBP
- Report
- October 2025
- 140 Pages
Global
From €5300EUR$5,950USD£4,626GBP
- Report
- June 2025
- 150 Pages
Global
From €5300EUR$5,950USD£4,626GBP
- Report
- May 2025
- 120 Pages
Global
From €5300EUR$5,950USD£4,626GBP
- Report
- May 2026
- 374 Pages
Global
From €5211EUR$5,850USD£4,549GBP
- Report
- May 2026
- 177 Pages
Global
From €5211EUR$5,850USD£4,549GBP
- Report
- May 2026
- 174 Pages
Global
From €5211EUR$5,850USD£4,549GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,491GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,491GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,491GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,491GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,491GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,491GBP
- Report
- January 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,491GBP
- Report
- January 2026
- 193 Pages
Global
From €3158EUR$3,545USD£2,756GBP
€3509EUR$3,939USD£3,063GBP
- Report
- January 2026
- 181 Pages
Global
From €3158EUR$3,545USD£2,756GBP
€3509EUR$3,939USD£3,063GBP
- Report
- January 2026
- 196 Pages
Global
From €3158EUR$3,545USD£2,756GBP
€3509EUR$3,939USD£3,063GBP
- Report
- January 2026
- 198 Pages
Global
From €3158EUR$3,545USD£2,756GBP
€3509EUR$3,939USD£3,063GBP
- Report
- January 2026
- 193 Pages
Global
From €3158EUR$3,545USD£2,756GBP
€3509EUR$3,939USD£3,063GBP
- Report
- January 2026
- 181 Pages
Global
From €3158EUR$3,545USD£2,756GBP
€3509EUR$3,939USD£3,063GBP

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness.
Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD.
Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more